On Invalid Date, Diamedica Therapeutics (NASDAQ: DMAC) reported Q4 2023 earnings per share (EPS) of -$0.14, up 0% year over year. Total Diamedica Therapeutics earnings for the quarter were -$5.03 million. In the same quarter last year, Diamedica Therapeutics's earnings per share (EPS) was -$0.14.
As of Q1 2024, Diamedica Therapeutics's earnings has grown year over year. Diamedica Therapeutics's earnings in the past year totalled -$19.30 million.
What is DMAC's earnings date?
Diamedica Therapeutics's earnings date is Invalid Date. Add DMAC to your watchlist to be reminded of DMAC's next earnings announcement.
What was DMAC's revenue last quarter?
On Invalid Date, Diamedica Therapeutics (NASDAQ: DMAC) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Diamedica Therapeutics's revenue was $0.00.
What was DMAC's revenue growth in the past year?
As of Q1 2024, Diamedica Therapeutics's revenue has grown null year over year. Diamedica Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.